Rafferty Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.17M | Sell |
157,499
-26,270
| -14% | -$696K | 0.01% | 431 |
|
|
2025
Q1 | $4.44M | Sell |
183,769
-87,394
| -32% | -$2.11M | 0.02% | 394 |
|
|
2024
Q4 | $10.9M | Buy |
271,163
+17,410
| +7% | +$701K | 0.04% | 272 |
|
|
2024
Q3 | $16.1M | Sell |
253,753
-81,813
| -24% | -$5.18M | 0.06% | 188 |
|
|
2024
Q2 | $17.8M | Buy |
335,566
+207,810
| +163% | +$11M | 0.07% | 165 |
|
|
2024
Q1 | $10.5M | Sell |
127,756
-285,522
| -69% | -$23.4M | 0.04% | 256 |
|
|
2023
Q4 | $7.69M | Sell |
413,278
-146,902
| -26% | -$2.73M | 0.03% | 341 |
|
|
2023
Q3 | $6.2M | Buy |
560,180
+217,827
| +64% | +$2.41M | 0.04% | 343 |
|
|
2023
Q2 | $5.55M | Sell |
342,353
-197,959
| -37% | -$3.21M | 0.03% | 387 |
|
|
2023
Q1 | $9M | Buy |
+540,312
| New | +$9M | 0.06% | 206 |
|
|
2022
Q1 | – | Sell |
-229,119
| Closed | -$1.05M | – | 1327 |
|
|
2021
Q4 | $1.05M | Buy |
229,119
+97,715
| +74% | +$450K | 0.01% | 840 |
|
|
2021
Q3 | $825K | Sell |
131,404
-54,032
| -29% | -$339K | 0.01% | 914 |
|
|
2021
Q2 | $1.11M | Sell |
185,436
-162,534
| -47% | -$974K | 0.01% | 841 |
|
|
2021
Q1 | $2.2M | Buy |
347,970
+291,934
| +521% | +$1.85M | 0.02% | 595 |
|
|
2020
Q4 | $315K | Sell |
56,036
-96,604
| -63% | -$543K | ﹤0.01% | 797 |
|
|
2020
Q3 | $888K | Buy |
152,640
+100,155
| +191% | +$583K | 0.01% | 591 |
|
|
2020
Q2 | $378K | Buy |
52,485
+38,152
| +266% | +$275K | 0.01% | 778 |
|
|
2020
Q1 | $67K | Sell |
14,333
-107,414
| -88% | -$502K | ﹤0.01% | 570 |
|
|
2019
Q4 | $976K | Sell |
121,747
-135,293
| -53% | -$1.08M | 0.02% | 557 |
|
|
2019
Q3 | $1.77M | Sell |
257,040
-226,052
| -47% | -$1.55M | 0.03% | 423 |
|
|
2019
Q2 | $4.01M | Buy |
483,092
+37,523
| +8% | +$311K | 0.07% | 213 |
|
|
2019
Q1 | $4.43M | Buy |
+445,569
| New | +$4.43M | 0.07% | 158 |
|